Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP081: Genital granulomatosis in Crohn’s disease: results of the ECCO CONFER studyECCO '18 Vienna
Year: 2018
Authors:

F. Dederichs1*, I. Iesalnieks2, M. Sladek3, C. Tzivinikos4, R. Hansen5, C. Muñoz6, P. Pavli7, M. Cavicchi8, V. Abitbol9, J.-F. Rahier10, S. Vavricka11, K. Katsanos12, E. Domènech13,14

1Kath. Krankenhaus Hagen, Hagen, Germany, 2Klinikum Bogenhausen, München, Germany, 3Jagiellonian University Medical College, Krakow, Poland, 4Royal London Hospital, London, UK, 5Royal Hospital for Children, Glasgow, UK, 6Villafranca del Hospital Universitario de Basurto, Bilbao, Spain, 7Canberra Hospital, Canberra, Australia, 8Cabinet Medical Créteil, Paris, France, 9Cochin Hospital, Paris, France, 10CHU Dinant-Godinne, Department of Gastroenterology, Yvoir, Belgium, 11Triemli Hospital, Zürich, Switzerland, 12University and Medical School of Ioannina, Ioannina, Greece, 13Hospital Universitari Germans Trias I Pujol, Badalona, Spain, 14CIBEREHD, Madrid, Spain

DOP082: Potential diagnostic biomarkers of ulcerative colitis-associated colorectal dysplasiaECCO '18 Vienna
Year: 2018
Authors:

A.-M. Merli1*, C. Massot1,2, N. Bletard3, F. Quesada Calvo1, D. Baiwir4, G. Mazzucchelli5, N. Smargiasso5, L. Servais6, C. Oury6, M.-C. De Pauw-Gillet7, E. De Pauw5, C. Coimbra Marques8, A. Colard9, A. Vijverman10, P. Delvenne3, M.-A. Meuwis1,2, E. Louis1,2

1GIGA-R, ULiège, Translational Gastroenterology, Liège, Belgium, 2CHU de Liège, Hepato-Gastroenterology and Digestive oncology, Liège, Belgium, 3CHU de Liège, Pathological anatomy and cytology, Liège, Belgium, 4GIGA proteomic facility, ULiège, Liège, Belgium, 5ULiège, Laboratory of mass spectrometry, Chemistry, Liège, Belgium, 6GIGA-R, ULiège, Laboratory of Thrombosis and Hemostasis, Liège, Belgium, 7ULiège, Mammalian cell culture laboratory, Liège, Belgium, 8CHU de Liège, Abdominal Surgery Department, Liège, Belgium, 9CHC de Liège, Gastroenterology, Liège, Belgium, 10CHR Citadelle de Liège, Gastroenterology and Digestive oncology, Liège, Belgium

DOP083: The association of appendectomy and colorectal cancer in ulcerative colitis patients: a systematic review and meta-analysisECCO '18 Vienna
Year: 2018
Authors:

M.E. Stellingwerf*, M.A. de Koning, W.A. Bemelman, G.R. D'Haens, C.J. Buskens

Academic Medical Center (AMC), Department of Surgery, Amsterdam, The Netherlands

DOP084: Toll-interacting protein promotes colitis-associated cancer by regulating immune cell infiltrationECCO '18 Vienna
Year: 2018
Authors:

C. Begka1*, S. Ragusa2, Y. Pu3, C. Mooser4, K. McCoy4, T. Petrova2, M.H. Maillard1

1Service of Gastroenterology and Hepatology, CHUV, University of Lausanne, Lausanne, Switzerland, 2Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland, 3Institute of Pathology, CHUV, Lausanne, Switzerland, 4Clinic for Visceral Surgery and Medicine, Department of Gastroenterology; University Hospital Bern Inselspital, Bern, Switzerland

DOP085: Innate mesenchymal MyD88 signals promote spontaneous intestinal tumorigenesisECCO '18 Vienna
Year: 2018
Authors:

V. Koliaraki1*, A. Henriques1, N. Chalkidi1, A. Polykratis2, M. Pasparakis2, G. Kollias1,3

1BSRC "Alexander Fleming", Vari, Greece, 2University of Cologne, Institute of Genetics, Cologne, Germany, 3University of Athens, School of Medicine, Athens, Greece

DOP086: Low FODMAP diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria and faecalibacterium prausnitzii in Quiescent inflammatory bowel disease: a randomised controlled trial and metagenomic analysisECCO '18 Vienna
Year: 2018
Authors:

S. Cox1*, A. Stagg2, S. Fromentin3, D. Ehrlich3,4, N. McCarthy2, N. Galleron3, F. Levenez3, M. Lomer1,5, J. Lindsay2,6, P. Irving7, K. Whelan1

1King's College London, Nutritional Sciences, London, UK, 2Queen Mary University of London, Centre for Immunobiology, London, UK, 3Institut National de la Recherche Agronomique, Microbiology, Paris, France, 4King's College London, Dental Institute, London, UK, 5Guy's and St Thomas' NHS Foundation Trust, Nutrition and dietetics, London, UK, 6Barts Health NHS Trust, Gastroenterology, London, UK, 7Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, UK

DOP087: The gut microbiota of pregnant women with Crohn’s disease and their babies is associated with abnormalities in the adaptive immune system: results from the MECONIUM studyECCO '18 Vienna
Year: 2018
Authors:

J. Torres1,2*, A. Seki3, L. Tarassishin4, J. Hu4, C. Eisele4, N. Nair4, G.J. Britton3,5, Q. Mao4, I. Mogno3,5, J.C. Clemente3,4, J. Faith4, J.-F. Colombel1, S. Mehandru1,3, I. Peter4

1Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, USA, 2Hospital Beatriz Ângelo, Gastroenterology, Loures, Portugal, 3Icahn School of Medicine at Mount Sinai, Precision Immunology Institute, New York, USA, 4Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, USA, 5Icahn School of Medicine at Mount Sinai, Institute for Genomics and Multiscale Biology, New York, USA

DOP088: Microbial dysbiosis increases experimental colitis by interfering with short-chain fatty acid-dependent mucosal Reg3B expressionECCO '18 Vienna
Year: 2018
Authors:

D. Bajic1, A. Su1, K. Hillmer1, R. Mejias-Luque2, S. Bluemel3, M. Docampo4, R. Schmid1, B. Schnabl3, M. van den Brink4, M. Gerhard2, C. Stein-Thoeringer1,4*

1Klinikum rechts der Isar, II. Med. Klinik, Munich, Germany, 2Institute of Med. Microbiology, TUM, Munich, Germany, 3University of California, San Diego, San Diego, USA, 4Memorial Sloan Kettering Cancer Center, New York, USA

DOP089: Individualised variations in the gut microbiota during remission precede Crohn’s disease flaresECCO '18 Vienna
Year: 2018
Authors:

T. Braun1, A. Di Segni1, S. Neuman1, N. Levhar1, M. Bubis1, O. Picard1, M. BenShoshan1, G. Efroni1, S. Farage Barhom1, E. Glick Saar1, A. Lahad1, D. Shouval1, B. Weiss1, A. Lahat1, R. Eliakim1, S. Ben-Horin1, U. Kopylov1, The Leona M. and Harry B. Helmsley Charitable Trust supported Israeli IBD Research Nucleus (IIRN), Y. Haberman1,2*

1Sheba Medical Center, Tel Hashomer, Israel, 2Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

DOP090: Risk factors for bacteraemia in hospitalised patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

I. Goren1,2*, A. Israel3, A. Brom4, G. Segal4

1Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel, 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 3Clalit health services, Jerusalem, Israel, 4Sheba Medical Center affiliated with Sackler faculty of medicine Tel Aviv University, Internal Medicine T, Ramat Gan, Israel

N001: Developing a quality of life score for Crohn’s anal fistula (CAF-QoL)ECCO '18 Vienna
Year: 2018
Authors:

S. Adegbola1*, L. Dibley2,3, K. Sahnan1, P. Tozer1,4, N. Yassin1,5, T. Wade2, A. Verjee6, R. Sawyer7, S. Mannick7, P. Lung1,8, R. Phillips1, O. Faiz1,4, J. Warusavitarne1,4, A. Hart1,9, C. Norton2

1St Mark's Academic Institute, Robin Phillip's Fistula Research Unit, London, UK, 2King's College London, Florence Nightingale School of Nursing and Midwifery, London, UK, 3University of Greenwich, Adult Nursing and Paramedic Science, London, UK, 4St Mark's Hospital, Department of Surgery, London, UK, 5University Hospitals Birmingham, Surgery, Birmingham, UK, 6Homerton University Hospital, Macmillan Cancer Care, London, UK, 7London, London, UK, 8St Mark's Hospital, Department of Radiology, London, UK, 9St Mark's Hospital, Department of IBD, London, UK

N002: A qualitative exploration into experiences of living with Crohn’s anal fistulaECCO '18 Vienna
Year: 2018
Authors:

S. Adegbola1*, L. Dibley2,3, K. Sahnan1, P. Tozer1,4, N. Yassin1,5, T. Wade2, A. Verjee6, R. Sawyer7, S. Mannick7, P. Lung1,8, R. Phillips1, O. Faiz1,4, J. Warusavitarne1,4, A. Hart1,9, C. Norton2

1St Mark's Academic Institute, Robin Phillip's Fistula Research Unit, London, UK, 2King's College London, Florence Nightingale School of Nursing and Midwifery, London, UK, 3University of Greenwich, Adult Nursing and Paramedic Science, London, UK, 4St Mark's Hospital, Department of Surgery, London, UK, 5University Hospitals Birmingham, Surgery, Birmingham, UK, 6Homerton University Hospital, Macmillan Cancer Care, London, UK, 7London, London, UK, 8St Mark's Hospital, Department of Radiology, London, UK, 9St Mark's Hospital, Department of IBD, London, UK

N003: Can patients schedule own treatment with infliximab (IFX)? A nurse quality control projectECCO '18 Vienna
Year: 2018
Authors:

Anne Berg and Jens Kjeldsen*, A. Berg

Odense Universitets Hospital, Department of Medical Gastroenterology, Odense, Denmark

N004: Differences in self-reported impact on health-related quality of life and symptoms in patients with Crohn’s disease and ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

K. Fritzell1*, J. Björk2, A. Storlåhls3, C. Hedin2

1Karolinska Institutet, NVS, Division of Nursing, Huddinge, Sweden, 2Karolinska Institutet, Department of Medicine, Stockholm, Sweden, 3Karolinska University Hospital, Gastroenterology Unit, Stockholm, Sweden

N005: Specialist nursing interventions for inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

E. Schirato1, E.V. Savarino2,3, M. Martinato1,4*

1University of Padova, Department of Medicine, Padova, Italy, 2University of Padova, Department of Surgical, Oncological and Gastroenterological Sciences, Padova, Italy, 3Azienda Ospedaliera di Padova, UOC Gastroenterologia, Padova, Italy, 4Azienda Ospedaliera di Padova, UOSD Progetti e Ricerca Clinica, Padova, Italy

N006: Psychosocial profiles in IBD according to the impairment risk of quality of lifeECCO '18 Vienna
Year: 2018
Authors:

A. Rivera Sequeiros1*, E. Gil García2, R. Chillón Martinez3, A. Gómez Vázquez4, M.R. Trenado Rodriguez1

1Hospital San Juan de Dios del Aljarafe, Internal Medicine, Seville, Spain, 2University of Seville, Nursing Department, Seville, Spain, 3University of Seville, Physiotherapy Department, Seville, Spain, 4San Juan de Dios del Aljarafe Hospital, Surgery Service, Seville, Spain

N007: Productivity and work reduced capacity in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

I. de Lima*, A. Andrade, A. Leite

Faculdade de Medicina da USP, Gastroenterology, São Paulo, Brazil

N008: Depressive symptoms independently predict a poorer health-related quality of life in patients with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

C. Zaltman1*, V. Bender Braulio1, S. R Dorf1, T. Nunes2

1Federal University of Rio de Janeiro, Internal Medicine, Rio de Janeiro, Brazil, 2Nestle Research Center, Digestive Health - Nutrition and Health Research, Lausanne, Switzerland

N009: Development of a self-care questionnaire for clinical assessment in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

U. Lovén Wickman1*, P. Yngman-Uhlin2, H. Hjortswang3, M. Wenemark4, H. Stjernman5, B. Riegel6, G. Hollman Frisman7

1Linköping University, Department of Primary Health Care in Kalmar County Council of Kalmar, Sweden, Blomstermåla, Sweden, 2Linköping University, Research and Development Unit and Department of Medical and Health Sciences, Linköping, Sweden, 3Linköping University, Department of Gastroenterology and Department of Clinical and Experimental Medicine, Linköping, Sweden, 4Linköping University, Centre for Organisational Support and Development, Region Östergötland, Linköping, Sweden, 5County council of Jönköping, Department of Medicine, County Hospital Ryhov, Jönköping, Sweden, 6University of Pennsylvania, US., Prof School of Nursing, Philadelphia, USA, 7Linköping university, Anaesthetics, Operations and Speciality Surgery Centre and Department of Medical and Health Sciences, Linköping, Sweden

N010: Impact of adalimumab’s patient support program on adherence to anti-TNFα therapy in patients with inflammatory bowel disease: A single-centre analysisECCO '18 Vienna
Year: 2018
Authors:

G. Lorenzon*, E.V. Savarino, F. Zingone, A. Rigo, F. Sonia, C. Marinelli, M. Inferrera, R. Caccaro, G. Girardin, B. Barberio, R. D'Incà

Azienda Ospedaliera di Padova, Surgery Oncology and Gastroenterology, Padua, Italy